Aeglea Biotherapeutics shares owned by Freestone Grove Partners
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Freestone Grove Partners
from 13F filings
Historical chart of Freestone Grove Partners investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Freestone Grove Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $2.0M | 23k | 88.78 |